Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001193125-26-049157·Longitude Capital Partners V, LLC
Schedule 13D ownership disclosure
VeraDermics, Inc.
Common Stock, $0.00001 par value per share · CUSIP: 922967104
Event date: 2026-02-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Longitude Capital Partners V, LLCReported CIK 0002018312
Shares: 2,600,399 · Class: 7.0%
- Longitude Venture Partners V, L.P.Reported CIK 0001935964
Shares: 2,600,399 · Class: 7.0%
- Longitude 103.8 East Partners, LLCReported CIK 0002094273
Shares: 2,053,474 · Class: 5.5%
- Longitude 103.8 East, L.P.Reported CIK 0002094269
Shares: 2,053,474 · Class: 5.5%
- Patrick G. EnrightReported CIK 0001253886
Shares: 4,653,873 · Class: 12.5%
- Juliet Tammenoms BakkerReported CIK 0001431159
Shares: 4,653,873 · Class: 12.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-049157
- Form type
- SCHEDULE 13D
- Filer
- Longitude Capital Partners V, LLC
- CIK
- CIK 2018312
- Filed
- Feb 12, 2026
- Reporting period
- Feb 05, 2026
- Description
- Schedule 13D beneficial ownership